PL375363A1 - Koniugaty steroidów, ich wytwarzanie i zastosowanie - Google Patents
Koniugaty steroidów, ich wytwarzanie i zastosowanieInfo
- Publication number
- PL375363A1 PL375363A1 PL03375363A PL37536303A PL375363A1 PL 375363 A1 PL375363 A1 PL 375363A1 PL 03375363 A PL03375363 A PL 03375363A PL 37536303 A PL37536303 A PL 37536303A PL 375363 A1 PL375363 A1 PL 375363A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- steroid conjugates
- steroid
- conjugates
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20020100335 | 2002-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375363A1 true PL375363A1 (pl) | 2005-11-28 |
Family
ID=36441275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375363A PL375363A1 (pl) | 2002-07-16 | 2003-07-14 | Koniugaty steroidów, ich wytwarzanie i zastosowanie |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7358379B2 (pl) |
| AU (1) | AU2003281165B2 (pl) |
| BR (1) | BR0312690A (pl) |
| CA (1) | CA2492297A1 (pl) |
| EA (1) | EA200500210A1 (pl) |
| MX (1) | MXPA05000615A (pl) |
| PL (1) | PL375363A1 (pl) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4215102A (en) * | 1979-01-05 | 1980-07-29 | Lee Sin H | Cytochemical agents and methods for the detection of steroid hormone receptors in human tissues |
| NZ196126A (en) | 1980-02-07 | 1985-05-31 | Commw Scient Ind Res Org | Increasing ovulation rate in female cattle |
| US5157049A (en) | 1988-03-07 | 1992-10-20 | The United States Of America As Represented By The Department Of Health & Human Services | Method of treating cancers sensitive to treatment with water soluble derivatives of taxol |
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5834213A (en) * | 1991-05-02 | 1998-11-10 | Baylor College Of Medicine | Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription |
| WO1993002691A1 (en) | 1991-08-09 | 1993-02-18 | Mount Sinai School Of Medicine Of The City University Of New York | Steroid hormone drug delivery |
| US5248796A (en) | 1992-06-18 | 1993-09-28 | Bristol-Myers Squibb Company | Taxol derivatives |
| HUP9701554D0 (en) | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
| ATE473759T1 (de) * | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
| WO2000028982A2 (en) * | 1998-11-19 | 2000-05-25 | The Board Of Trustees For The University Of Arkansas | Increasing bone strength with selected bisphosphonates |
| EP1104667A1 (en) | 1999-11-29 | 2001-06-06 | The Procter & Gamble Company | Disposable absorbant article having fecal management layer |
| NO314537B1 (no) | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
| GB0010683D0 (en) | 2000-05-03 | 2000-06-28 | Univ Bristol | Cancer therapy |
| HU229207B1 (en) * | 2000-09-14 | 2013-09-30 | Univ British Columbia | Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine regulated tumor therapy |
| US7199115B2 (en) * | 2004-04-19 | 2007-04-03 | Schering Ag | 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them |
-
2003
- 2003-07-14 BR BR0312690-0A patent/BR0312690A/pt not_active Application Discontinuation
- 2003-07-14 EA EA200500210A patent/EA200500210A1/ru unknown
- 2003-07-14 MX MXPA05000615A patent/MXPA05000615A/es not_active Application Discontinuation
- 2003-07-14 PL PL03375363A patent/PL375363A1/pl not_active Application Discontinuation
- 2003-07-14 CA CA002492297A patent/CA2492297A1/en not_active Abandoned
- 2003-07-14 AU AU2003281165A patent/AU2003281165B2/en not_active Ceased
-
2006
- 2006-04-04 US US11/398,022 patent/US7358379B2/en not_active Expired - Fee Related
-
2008
- 2008-03-28 US US12/058,375 patent/US20080267875A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003281165A1 (en) | 2004-02-02 |
| EA200500210A1 (ru) | 2005-06-30 |
| US20080267875A1 (en) | 2008-10-30 |
| BR0312690A (pt) | 2005-05-03 |
| MXPA05000615A (es) | 2005-11-17 |
| AU2003281165B2 (en) | 2006-08-03 |
| CA2492297A1 (en) | 2004-01-22 |
| US20060178295A1 (en) | 2006-08-10 |
| US7358379B2 (en) | 2008-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2002002659A0 (en) | 3-Nitrogen-6,7-dioxygen steroids and uses related thereto | |
| IL148545A0 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof | |
| IL172094A0 (en) | Polymeric conjugates and methods for the preparation thereof | |
| MXPA03001050A (es) | Dispositivo desacelerador de rotacion y utilizacion del mismo. | |
| IL158115A0 (en) | Sapogenin derivatives, their synthesis and use, and methods based upon their use | |
| IL184288A0 (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
| IL164627A0 (en) | Novel biomaterials, their preparation and use | |
| AU2003265576A8 (en) | Corticosteroid conjugates and uses thereof | |
| MXPA03004932A (es) | 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe. | |
| AU2002364051A1 (en) | Anti-cancer combination and use thereof | |
| ZA200703876B (en) | 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof | |
| PL394604A1 (pl) | Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna | |
| PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
| AU2003296369A8 (en) | Imminoamines and preparation thereof | |
| ZA200210316B (en) | Composition and its therapeutic use. | |
| AU2003298129A1 (en) | Floor-furnace chimney and the use thereof | |
| HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
| HRP20050142A2 (en) | Steroid conjugates, preparation thereof and the use thereof | |
| TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
| ZA200307846B (en) | Latex and its preparation. | |
| PL375309A1 (pl) | Pochodne acyloksypirolidyny, ich wytwarzanie i ich zastosowanie lecznicze | |
| AU2003281698A8 (en) | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof | |
| AU2003299336A8 (en) | Diphosphines, preparation and uses thereof | |
| HUP0203678A3 (en) | Nitro-sulfobenzamide-derivatives, preparation and use thereof | |
| PL375363A1 (pl) | Koniugaty steroidów, ich wytwarzanie i zastosowanie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |